Screen‐positive rate in cell‐free DNA screening for microdeletion 22q11.2
Prenatal Diagnosis · 2023
DOI: 10.1002/pd.6328 ↗At a glance
Journal article in Prenatal Diagnosis, 2023. Written by Kai Lüthgens and 3 co-authors. Institution: Cenata GmbH, Tuebingen, Germany. Major MEDLINE topics: Cell-Free Nucleic Acids. Cited 2 times so far (Crossref); 28 references. The full text is freely available (open access, CC BY 4.0).
Abstract (original language)
Objective
To examine the impact of the fetal fraction (FF) on the screen‐positive rate in screening for microdeletion 22q11.2.
Methods
This study is based on samples that were analyzed using the Harmony® Prenatal Test (Roche Inc). The study cohort comprised samples from women with singleton pregnancies who were at least 16 years old and at least at 11 weeks' gestation. Logistic regression analysis was used to determine significant covariates that carry an impact on the screen‐positive rate.
Results
The study population consisted of 52,019 pregnancies, including 309 pregnancies with a high‐risk result for microdeletion 22q11.2. Thus, the overall screen‐positive rate was 0.59%. In the low‐risk group, the FF was 10.1%, and in the high‐risk group, it was 7.3%. Regression analysis indicated a strong correlation between the FF and the screen‐positive rate. In the cases with an FF of
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Cenata GmbH, Tuebingen, Germany.
- Department of Women's Health, University Women's Hospital, Tuebingen, Germany.
ORCID profiles: Kai Lüthgens, Karl Oliver Kagan
Cite
APA
Lüthgens, K., Sinzel, M., Kolar, M., & Kagan, K. O. (2023). Screen‐positive rate in cell‐free DNA screening for microdeletion 22q11.2. Prenatal Diagnosis. https://doi.org/10.1002/pd.6328
Vancouver
Lüthgens K, Sinzel M, Kolar M, Kagan KO. Screen‐positive rate in cell‐free DNA screening for microdeletion 22q11.2. Prenatal Diagnosis. 2023. doi:10.1002/pd.6328
BibTeX
@article{Lthgens2023,
author = {Lüthgens, Kai and Sinzel, Monika and Kolar, Miriam and Kagan, Karl Oliver},
title = {Screen‐positive rate in cell‐free DNA screening for microdeletion 22q11.2},
journal = {Prenatal Diagnosis},
year = {2023},
doi = {10.1002/pd.6328}
}
EUVIMED